 |
PDBsum entry 1r29
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
1r29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Mechanism of smrt corepressor recruitment by the bcl6 btb domain.
|
 |
|
Authors
|
 |
K.F.Ahmad,
A.Melnick,
S.Lax,
D.Bouchard,
J.Liu,
C.L.Kiang,
S.Mayer,
S.Takahashi,
J.D.Licht,
G.G.Privé.
|
 |
|
Ref.
|
 |
Mol Cell, 2003,
12,
1551-1564.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
BCL6 encodes a transcription factor that represses genes necessary for the
terminal differentiation of lymphocytes within germinal centers, and the
misregulated expression of this factor is strongly implicated in several types
of B cell lymphoma. The homodimeric BTB domain of BCL6 (also known as the POZ
domain) is required for the repression activity of the protein and interacts
directly with the SMRT and N-CoR corepressors that are found within large
multiprotein histone deacetylase-containing complexes. We have identified a 17
residue fragment from SMRT that binds to the BCL6 BTB domain, and determined the
crystal structure of the complex to 2.2 A. Two SMRT fragments bind symmetrically
to the BCL6 BTB homodimer and, in combination with biochemical and in vivo data,
the structure provides insight into the basis of transcriptional repression by
this critical B cell lymphoma protein.
|
 |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Structure of the BCL6 BTB Domain/SMRT-BBD
Complex(A) Ribbon diagram of the 2:2 complex. The
crystallographic asymmetric unit contains the entire four-chain
structure. The two chains of the BCL6 BTB domain dimer are
colored blue and red, and the two SMRT chains are colored yellow
and green. The N termini of the two SMRT chains are
labeled.(B–D) View of the BCL6 BTB domain displayed as a
solvent accessible surface colored according to the two chains
of the BTB dimer (blue and white), with the two SMRT fragments
rendered in stick representation (oxygens in red, nitrogens in
blue, and the carbons of the two corepressor chains colored in
either yellow or green, as in [A]). The two nonoverlapping
surfaces of the BCL6 BTB dimer that are buried upon peptide
binding are highlighted in purple. (B) View in same orientation
as in [A]. (C) “Bottom” of the complex, viewed along the
molecular pseudo-2-fold axis. (D) Ser-1424 (hidden by His-116 in
this view) and Ile-1425 of SMRT are buried in a groove formed
in part by Arg-13′ (α1′) and His-116 (α6) from the
two chains of the BCL6 BTB domain.(E) Sequence alignment of
selected human BTB/zinc finger proteins and the observed
secondary structure of the BCL6 BTB domain. The
residue-by-residue surfaces buried due to interactions with the
yellow SMRT peptide are indicated with red and blue bars (color
scheme according to [A]). HIC-1 has a 13 amino acid insert at
the position indicated by the three asterisks.
|
 |
Figure 4.
Figure 4. Peptide Binding Interactions(A) Schematic drawing
of the contacts between the BCL6 BTB domain and the “yellow”
SMRT chain (colors as in Figure 3A). Nearly identical contacts
are observed in the other contact surface.(B) Highlight of the
interactions between SMRT 1427–1430 and the BCL6 BTB
domain.(C) Interactions of SMRT 1424–1426 with the BCL6 BTB
domain.(D) To view the interactions between region 1414–1423
of the SMRT-BBD peptide and BTB β1′, the BCL6 helix α6 (red
chain) has been made transparent.(E) Superposition of the two
crystallographically independent SMRT peptides from the complex,
with carbons shown in yellow and green as in Figure 3. The six
waters from each site that participate in the bridging SMRT/BCL6
interactions are indicated as yellow or green spheres.(F)
Mutations in the BCL6 BTB peptide binding pocket reduce the
affinity for the SMRT peptide. His-tagged Trx-(SMRT-BBD) was
mixed with three different forms of the BCL6 BTB domain, and the
load (“L”), flow through (“FT”), wash (“W”), and
elute (“E”) fractions from each copurification trial were
analyzed by SDS-PAGE.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2003,
12,
1551-1564)
copyright 2003.
|
 |
|
|
|
|
 |